Fingerprint
Dive into the research topics of 'The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment
Hong Zhou, Suhendan Ekmekcioglu, John W. Marks, Khalid A. Mohamedali, Kaushal Asrani, Keeley K. Phillips, Sharron A.N. Brown, Emily Cheng, Michele B. Weiss, Walter N. Hittelman, Nhan L. Tran, Hideo Yagita, Jeffrey A. Winkles, Michael G. Rosenblum
Research output: Contribution to journal › Article › peer-review
43
Scopus
citations